Status:
COMPLETED
Stigma and a Shared Decision Aid
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Opioid Use Disorder
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
A major barrier for the uptake of evidence-based interventions to address the ongoing opioid epidemic in the US, especially in rural regions, is stigma, which occurs at many levels, including that of ...
Detailed Description
In the past decade, the US opioid crisis has emerged as a leading cause of death among adults. It has also led to an increase in invasive bacterial and fungal infections; and HIV and hepatitis C virus...
Eligibility Criteria
Inclusion
- Patients from a rural community currently admitted or recently admitted to Barnes-Jewish Hospital
- Admission must be for an infection associated with intravenous drug use
- Patient must be willing to speak with healthcare provider about medications for opioid use disorder (MOUDs)
- patient must be over 18 years old
- must be able to complete electronic survey written in English
Exclusion
- None
Key Trial Info
Start Date :
April 7 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2024
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT05352412
Start Date
April 7 2022
End Date
March 31 2024
Last Update
June 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Barnes Jewish Hospital
St Louis, Missouri, United States, 63110